|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
AU627226B2
(en)
|
1988-08-25 |
1992-08-20 |
Liposome Company, Inc., The |
Influenza vaccine and novel adjuvants
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
DE68907045T2
(de)
|
1989-01-17 |
1993-12-02 |
Eniricerche Spa |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH04506662A
(ja)
|
1989-07-14 |
1992-11-19 |
アメリカン・サイアナミド・カンパニー |
接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
CN1176658A
(zh)
|
1994-10-24 |
1998-03-18 |
蛇药制品有限公司 |
治疗和预防艰难梭菌疾病的疫苗和抗毒素
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
WO1997002836A1
(en)
|
1995-07-07 |
1997-01-30 |
Oravax, Inc. |
Clostridium difficile toxins as mucosal adjuvants
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
WO1998008540A1
(en)
|
1996-08-28 |
1998-03-05 |
Ophidian Pharmaceuticals, Inc. |
Multivalent vaccine for clostridium botulinum neurotoxin
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
AU746859B2
(en)
*
|
1997-06-20 |
2002-05-02 |
Imperial College Of Science, Technology And Medicine |
Immonogenic fragments of toxin a of clostridium difficile
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
AU1145699A
(en)
|
1997-09-05 |
1999-03-22 |
Smithkline Beecham Biologicals (Sa) |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
EP1053015A2
(en)
|
1998-02-12 |
2000-11-22 |
American Cyanamid Company |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
US20020009429A1
(en)
*
|
1999-01-29 |
2002-01-24 |
Galagen, Inc. |
Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
|
|
JP2002539273A
(ja)
|
1999-03-19 |
2002-11-19 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
US6733760B1
(en)
*
|
1999-04-09 |
2004-05-11 |
Techlab, Inc. |
Recombinant toxin A/toxin B vaccine against Clostridium difficile
|
|
CA2365914A1
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
EP2502998A3
(en)
|
1999-04-09 |
2013-02-27 |
Intercell USA, Inc. |
Recombinant toxin A/ToxinB vaccine against clostridium difficile
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2001258107A1
(en)
*
|
2000-05-10 |
2001-11-20 |
Glycodesign Inc. |
Designing modulators for glycosyltransferases
|
|
ATE439372T1
(de)
|
2000-10-27 |
2009-08-15 |
Novartis Vaccines & Diagnostic |
Nukleinsäuren und proteine von gruppen a und b- streptokokken
|
|
WO2002079410A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Basf Plant Science Gmbh |
Glucan chain length domains
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
AU2003299527A1
(en)
|
2002-06-17 |
2004-06-07 |
Jimmy D. Ballard |
Mutant of clostridium difficile toxin b and methods of use
|
|
US20040235139A1
(en)
*
|
2002-12-23 |
2004-11-25 |
Demain Arnold L. |
Clostridium difficile culture and toxin production methods
|
|
EP2857418B1
(en)
|
2004-02-06 |
2017-07-26 |
University of Massachusetts |
Antibodies against Clostridium difficile toxins and uses thereof
|
|
EP1833510A4
(en)
|
2004-12-27 |
2010-02-10 |
Progenics Pharmaceuticals Neva |
ORAL ADMINISTRATION ANTITOXIN ANTIBODIES AND METHODS OF MAKING AND USING THE SAME
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
CN101500581B
(zh)
|
2006-06-08 |
2013-10-30 |
科内尔研究基金会 |
编码艰难梭菌毒素a和毒素b受体结合域的密码子优化dna分子及其使用方法
|
|
JP5345532B2
(ja)
|
2006-08-02 |
2013-11-20 |
ヨハネス・グーテンベルク−ウニヴェルジテート・マインツ |
Ｌｃｔ中毒に対する医薬品
|
|
CA2693958A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Emergent Biosolutions, Inc. |
Chemically modified peptides with improved immunogenicity
|
|
US8524444B2
(en)
*
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
|
EP2318515A4
(en)
|
2008-08-06 |
2012-11-14 |
Emergent Product Dev Uk Ltd |
DIFFICULT CLOSTRIDIUM VACCINES, AND METHODS OF USE
|
|
EP2405940B1
(en)
|
2009-02-20 |
2021-08-04 |
Secretary of State for Health and Social Care |
Antibodies to clostridium difficile toxins
|
|
CN102612562A
(zh)
*
|
2009-08-27 |
2012-07-25 |
色奈普提科研究有限公司 |
一种新的用于生成诱导性多能干(iPS)细胞或组织特异性细胞的蛋白质递送系统
|
|
US10046040B2
(en)
|
2009-11-16 |
2018-08-14 |
University Of Maryland, Baltimore |
Multivalent live vector vaccine against Clostridium difficile-associated disease
|
|
WO2011063346A1
(en)
|
2009-11-20 |
2011-05-26 |
Northshore University Health System Research Institute |
Targeting of the c-terminal segment of c. difficile toxin b for improved clinical diagnosis, prevention, and treatment
|
|
JP2013512916A
(ja)
|
2009-12-02 |
2013-04-18 |
タフツ ユニバーシティー |
免疫原としてのＣｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅの無毒の組換えホロトキシン
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
EP2553102B1
(en)
|
2010-03-30 |
2015-12-09 |
Pfenex Inc. |
High level expression of recombinant toxin proteins
|
|
BR112012026021B1
(pt)
*
|
2010-04-15 |
2022-05-03 |
Progenics Pharmaceuticals, Inc |
Anticorpos, seus fragmentos de ligação ao antígeno e seus usos, composições e uso das mesmas, linhagem de células de hibridoma, kit, ácido nucleico, e vetor de expressão
|
|
SMT201700124T1
(it)
|
2010-09-03 |
2017-05-08 |
Valneva Austria Gmbh |
Polipeptide isolato delle proteine di tossina a e tossina b di c. difficile e relativi usi
|
|
US8431361B2
(en)
|
2010-09-17 |
2013-04-30 |
Board Of Regents Of The University Of Oklahoma |
Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
|
|
GB201016742D0
(en)
|
2010-10-05 |
2010-11-17 |
Health Prot Agency |
Clostridium difficile antigens
|
|
WO2012118693A1
(en)
|
2011-02-28 |
2012-09-07 |
Northshore University Healthsystem |
Methods of diagnosing clostridium difficile infection
|
|
ES2969952T3
(es)
*
|
2011-04-22 |
2024-05-23 |
Wyeth Llc |
Composiciones relacionadas con una toxina mutante de Clostridium difficile y sus procedimientos
|
|
EP3327126A1
(en)
|
2011-05-27 |
2018-05-30 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
AR087716A1
(es)
*
|
2011-08-31 |
2014-04-09 |
Valent Biosciences Corp |
Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
|
|
AR089797A1
(es)
*
|
2012-01-27 |
2014-09-17 |
Merck Sharp & Dohme |
Vacunas contra clostridum difficile que comprenden toxinas recombinantes
|
|
GB201223342D0
(en)
*
|
2012-12-23 |
2013-02-06 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|